Joysoual, Mita Rani, et al. “Safety of Empagliflozin As Add-on Therapy in Patients With Uncontrolled Type 2 Diabetes Mellitus”. KYAMC Journal, vol. 16, no. 3, June 2026, pp. 119-22, doi:10.3329/kyamcj.v16i3.88022.